ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,186 | +7.9% | 296 | 0.0% | 0.00% | – |
Q2 2023 | $15,934 | +132683.3% | 296 | +2.1% | 0.00% | – |
Q1 2023 | $12 | 0.0% | 290 | 0.0% | 0.00% | – |
Q4 2022 | $12 | -99.9% | 290 | 0.0% | 0.00% | – |
Q3 2022 | $11,000 | +22.2% | 290 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | +12.5% | 290 | 0.0% | 0.00% | – |
Q1 2022 | $8,000 | -86.9% | 290 | -80.8% | 0.00% | – |
Q4 2021 | $61,000 | -3.2% | 1,510 | -20.9% | 0.00% | – |
Q3 2021 | $63,000 | -10.0% | 1,910 | -5.0% | 0.00% | – |
Q2 2021 | $70,000 | +366.7% | 2,010 | +390.2% | 0.00% | – |
Q1 2021 | $15,000 | +25.0% | 410 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | +300.0% | 410 | +272.7% | 0.00% | – |
Q3 2020 | $3,000 | -25.0% | 110 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | -98.6% | 110 | -98.4% | 0.00% | -100.0% |
Q1 2020 | $277,000 | -33.9% | 6,790 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $419,000 | +84.6% | 6,790 | +117.6% | 0.00% | +100.0% |
Q3 2019 | $227,000 | -63.6% | 3,120 | -58.9% | 0.00% | -66.7% |
Q2 2019 | $624,000 | +16.6% | 7,588 | 0.0% | 0.01% | +20.0% |
Q1 2019 | $535,000 | +10600.0% | 7,588 | +6798.2% | 0.01% | – |
Q4 2018 | $5,000 | -16.7% | 110 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 110 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | -96.4% | 110 | -96.3% | 0.00% | -100.0% |
Q1 2018 | $192,000 | -4.0% | 3,010 | -3.2% | 0.00% | 0.0% |
Q4 2017 | $200,000 | +22.7% | 3,110 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $163,000 | +19.9% | 3,110 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $136,000 | -11.7% | 3,110 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $154,000 | -59.0% | 3,110 | -49.8% | 0.00% | -60.0% |
Q4 2016 | $376,000 | +77.4% | 6,200 | +93.8% | 0.01% | +66.7% |
Q3 2016 | $212,000 | +18.4% | 3,200 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $179,000 | +65.7% | 3,200 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $108,000 | – | 3,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |